可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪肝病诊疗指南[J]. 中华肝脏杂志, 2006,14(3):161-163.
[2] Bedogni G, Bellentani S. Fatty liver, how frequent is it and why[J]. Ann Hepatol, 2004, 3(2):63-65.
[3] Donati G, Stagni B, Piscagli F, et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance[J]. Gut, 2004, 53(7):1020-1023.
[4] Fan JG, Zhu J, Li XJ, et al. Prevalence of and risk favtors for liver in a general population of shanghai, China[J]. J Hepatol, 2005, 43(3):508-514.
[5] Methta K, van Thiel DH, Shah N, et al. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants[J]. Nutr Rev, 2002, 60(9):289-293.
[6]何淑梅,孔俭,牛俊奇. 非酒精性脂肪性肝病研究现状及进展[J].中国老年学杂志, 2008, 28(4):725-727.
[7] 展玉涛. 非酒精性脂肪肝与心血管疾病[J]. 中华内科杂志, 2007, 46(10):868-869.
[8] 徐新娟,胡广梅,王明建,等. 高血压合并非酒精性脂肪肝的临床特点[J]. 中华高血压杂志, 2008, 16(11):979-983.
[9]Santoliquido A, Di Campli C, Miele L, et al. Hepatic steatosis and vascular disease[J]. Eur Rev Med Pharmacol Sci, 2005, 9(5):269-271.
[10]Videla LA, Rodrigo R, Araya J, et al. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease[J]. Trends Mol Med, 2006, 12(12):555-558.